New hope for advanced cancer patients as experimental drug enters human trials

NCT ID NCT04896697

First seen May 10, 2026 · Last updated May 14, 2026 · Updated 2 times

Summary

This study tests a new drug called vilastobart, alone or with another drug (atezolizumab), in people with advanced solid tumors that have not responded to standard treatments. The goal is to see if the drug is safe and can shrink tumors. About 136 adults with various advanced cancers will take part.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • California Cancer Associates for Research and Excellence, cCARE

    Encinitas, California, 92024, United States

  • California Cancer Associates for Research and Excellence, cCARE

    San Marcos, California, 92069, United States

  • Carolina BioOncology Institute

    Huntersville, North Carolina, 28078, United States

  • City of Hope

    Duarte, California, 91010, United States

  • City of Hope-Lennar

    Irvine, California, 92618, United States

  • City of Hope-Upland

    Upland, California, 91786, United States

  • Duke University Medical Center

    Durham, North Carolina, 27710, United States

  • Mary Crowley Cancer Research

    Dallas, Texas, 75230, United States

  • Massachusetts General Hospital

    Boston, Massachusetts, 02114, United States

  • Mayo Clinic Hospital

    Phoenix, Arizona, 85054, United States

  • Mayo Clinic Hospital

    Jacksonville, Florida, 32224, United States

  • Mayo Clinic Hospital

    Rochester, Minnesota, 55905, United States

  • NEXT Virginia

    Fairfax, Virginia, 22031, United States

  • Next Oncology

    Austin, Texas, 78758, United States

  • Sarah Cannon Research Institute at Florida Cancer Specialists

    Orlando, Florida, 32827, United States

  • Tranquil Clinical Research

    Webster, Texas, 77598, United States

  • UCLA Hematology/Oncology- Santa Monica

    Santa Monica, California, 90404, United States

  • USC/Norris Comprehensive Cancer Center

    Los Angeles, California, 90033, United States

  • University of Pittsburgh Medical Center- Hillman Cancer Center

    Pittsburgh, Pennsylvania, 15232, United States

Conditions

Explore the condition pages connected to this study.